Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13601808 | 0.93 | EGLN2 (0.61) | EGLN2EGLN1 | |
| SCHEMBL13601815 | 0.92 | EGLN2 (0.50) | EGLN2EGLN1 | |
| SCHEMBL13601818 | 0.89 | EGLN2 (0.48) | EGLN2EGLN1 | |
| SCHEMBL13601807 | 0.89 | EGLN2 (0.48) | EGLN2EGLN1 | |
| SCHEMBL29627762 | 0.87 | EGLN2 (0.64) | EGLN2EGLN1 | |
| SCHEMBL13601812 | 0.85 | EGLN2 (0.49) | EGLN2EGLN1 | |
| SCHEMBL13601805 | 0.83 | EGLN2 (0.46) | EGLN2EGLN1 | |
| SCHEMBL13601817 | 0.83 | EGLN1 (0.59) | EGLN2EGLN1 | |
| SCHEMBL21361727 | 0.80 | EGLN1 (0.70) | EGLN2EGLN1 | |
| SCHEMBL29726498 | 0.80 | EGLN1 (0.70) | EGLN2EGLN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7629357-B2 | Antihypoxic agents; adjust concentration of erythropoietin concentration in blood; strokes; antiepileptic agents; neurodegenerative disease ; liver disorders; antiischemic agents | FIBROGEN, INC. (US) | 2009-12-08 | — | — | US | disclosed |
| US-7629357-B2 | Antihypoxic agents; adjust concentration of erythropoietin concentration in blood; strokes; antiepileptic agents; neurodegenerative disease ; liver disorders; antiischemic agents | FIBROGEN, INC. (US) | 2009-12-08 | — | — | US | disclosed |